Patents by Inventor Colin O'Banion

Colin O'Banion has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME
    Publication number: 20240392316
    Abstract: The disclosure provides nucleic acids (comprising AAV expression cassettes), AAV vectors, and compositions for use in methods for treating and/or delaying the onset of diseases associated with mutations in the mecp2 gene, such as Rett Syndrome. Also, provided herein are methods for treating and/or delaying the onset of brain-derived neurotrophic factor (BDNF)-associated diseases.
    Type: Application
    Filed: May 31, 2024
    Publication date: November 28, 2024
    Applicant: Sarepta Therapeutics, Inc.
    Inventor: Colin O'Banion
  • Adeno-associated virus vectors for treatment of Rett syndrome
    Patent number: 12104163
    Abstract: The disclosure provides nucleic acids (comprising AAV expression cassettes), AAV vectors, and compositions for use in methods for treating and/or delaying the onset of diseases associated with mutations in the mecp2 gene, such as Rett Syndrome. Also, provided herein are methods for treating and/or delaying the onset of brain-derived neurotrophic factor (BDNF)-associated diseases.
    Type: Grant
    Filed: August 19, 2021
    Date of Patent: October 1, 2024
    Assignee: Sarepta Therapeutics, Inc.
    Inventor: Colin O'Banion
  • ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME
    Publication number: 20230304038
    Abstract: The disclosure provides nucleic acids (comprising AAV expression cassettes), AAV vectors, and compositions for use in methods for treating and/or delaying the onset of diseases associated with mutations in the mecp2 gene, such as Rett Syndrome. Also, provided herein are methods for treating and/or delaying the onset of brain-derived neurotrophic factor (BDNF)-associated diseases.
    Type: Application
    Filed: August 19, 2021
    Publication date: September 28, 2023
    Inventor: Colin O'BANION
  • ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF RETT SYNDROME
    Publication number: 20220056478
    Abstract: The disclosure provides nucleic acids (comprising AAV expression cassettes), AAV vectors, and compositions for use in methods for treating and/or delaying the onset of diseases associated with mutations in the mecp2 gene, such as Rett Syndrome. Also, provided herein are methods for treating and/or delaying the onset of brain-derived neurotrophic factor (BDNF)-associated diseases.
    Type: Application
    Filed: August 19, 2021
    Publication date: February 24, 2022
    Inventor: Colin O'Banion